PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Hyperglycemic Mice Increases the Risk of Hemorrhagic Transformation of Ischemic Stroke

[Figure: see text].

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Stroke (1970) 2021-09, Vol.52 (9), p.e545-e547
Hauptverfasser:	Nativel, Brice, Ramin-Mangata, Stéphane, Couret, David, Planesse, Cynthia, Roche, Mathias, Gallo, Antonio, Meilhac, Olivier, Lambert, Gilles, Bourane, Steeve
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Atherosclerosis - genetics Atherosclerosis - metabolism Brain Ischemia - genetics Brain Ischemia - metabolism Cardiovascular System & Cardiology Clinical Neurology Hemorrhage - genetics Ischemic Stroke - genetics Ischemic Stroke - metabolism Life Sciences Life Sciences & Biomedicine Mice Mice, Obese Neurosciences & Neurology Peripheral Vascular Disease Proprotein Convertase 9 - genetics Proprotein Convertase 9 - metabolism Risk Factors Science & Technology Stroke - genetics Stroke - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!